UBS Group’s Health Assurance Acquisition Corp. SAIL Securities HAACU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-2,122
Closed -$21K 11871
2022
Q3
$21K Buy
2,122
+474
+29% +$4.71K ﹤0.01% 7373
2022
Q2
$16K Sell
1,648
-73
-4% -$725 ﹤0.01% 7256
2022
Q1
$17K Sell
1,721
-1,392
-45% -$13.8K ﹤0.01% 7715
2021
Q4
$31K Buy
3,113
+867
+39% +$8.7K ﹤0.01% 7383
2021
Q3
$23K Buy
2,246
+550
+32% +$5.55K ﹤0.01% 7041
2021
Q2
$18K Sell
1,696
-299
-15% -$3.19K ﹤0.01% 7477
2021
Q1
$21K Buy
+1,995
New +$24.8K ﹤0.01% 7357

Other funds holding HAACU

UBS Group's HAACU Position: Q4 2022 in Review

UBS Group sold out of Health Assurance Acquisition Corp. SAIL Securities (HAACU) in Q4 2022, closing a stake of 2,122 shares — an estimated $21K sold.

UBS Group first reported a position in HAACU in Q1 2021 and held it in 7 quarters. The position peaked at $31K in Q4 2021. 1 fund tracked by Wall St. Rank holds HAACU as of Q4 2022.

  • UBS Group reported no remaining Health Assurance Acquisition Corp. SAIL Securities position as of Q4 2022 after selling out during the quarter.
  • UBS Group sold 2,122 Health Assurance Acquisition Corp. SAIL Securities shares in Q4 2022, an estimated $21K.
  • UBS Group first reported a position in Health Assurance Acquisition Corp. SAIL Securities in Q1 2021 and held it in 7 quarters.
  • UBS Group's Health Assurance Acquisition Corp. SAIL Securities position peaked at $31K in Q4 2021.
  • 1 fund tracked by Wall St. Rank held Health Assurance Acquisition Corp. SAIL Securities as of Q4 2022.

Based on UBS Group's 13F filing for Q4 2022, filed 8 Feb 2023.